118 related articles for article (PubMed ID: 3937179)
1. An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets.
Panse M; Block HU; Förster W; Mest HJ
Prostaglandins; 1985 Dec; 30(6):1031-40. PubMed ID: 3937179
[TBL] [Abstract][Full Text] [Related]
2. Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers.
Sinzinger H; Virgolini I; Peskar BA
Thromb Res; 1989 Feb; 53(3):261-9. PubMed ID: 2497545
[TBL] [Abstract][Full Text] [Related]
3. Effect on nitroglycerin and other organic nitrates on the in-vitro biosynthesis of arachidonic acid-metabolites in washed human platelets.
Wirthumer-Hoche C; Silberbauer K; Sinzinger H
Prostaglandins Leukot Med; 1984 Sep; 15(3):317-23. PubMed ID: 6436836
[TBL] [Abstract][Full Text] [Related]
4. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
[TBL] [Abstract][Full Text] [Related]
6. Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay.
Hecker M; Haurand M; Ullrich V; Diczfalusy U; Hammarström S
Arch Biochem Biophys; 1987 Apr; 254(1):124-35. PubMed ID: 3579292
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid.
Morita I; Takahashi R; Saito Y; Murota S
J Biol Chem; 1983 Sep; 258(17):10197-9. PubMed ID: 6309794
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid.
Patscheke H
Biochem Pharmacol; 1985 Apr; 34(8):1151-6. PubMed ID: 3922373
[TBL] [Abstract][Full Text] [Related]
9. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
10. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
[TBL] [Abstract][Full Text] [Related]
11. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
Busse WD; Seuter F
Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
14. [Protein binding of thromboxane--one of the sources of error in thromboxane determination].
Wirthumer-Hoche C; Sinzinger H
Wien Klin Wochenschr; 1985 Mar; 97(6):282-5. PubMed ID: 3993037
[TBL] [Abstract][Full Text] [Related]
15. Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders.
Satoh K; Takamatsu S; Sakuta S; Mizuno S; Metoki H; Takamatsu M
Jpn Circ J; 1981 Dec; 45(12):1335-41. PubMed ID: 7321143
[TBL] [Abstract][Full Text] [Related]
16. Modulation of platelet thromboxane and malonaldehyde by dietary vitamin E and linoleate.
Hamelin SS; Chan AC
Lipids; 1983 Mar; 18(3):267-9. PubMed ID: 6855486
[TBL] [Abstract][Full Text] [Related]
17. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
[TBL] [Abstract][Full Text] [Related]
18. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
Best LC; Jones PB; Russell RG
Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
[No Abstract] [Full Text] [Related]
20. Arachidonic acid-induced malondialdehyde formation in rat platelets. Kinetic aspects and inhibition by acetylsalicylic acid and indomethacin.
de Gaetano G; Rajtar G; Livio M; Merino J
Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):85-9. PubMed ID: 7393351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
